Cancer Family
Gastric Neoplasm
CI-CAN-00000185Explore in graph →
Non-malignant720 active trials4 approved drugs55 evidence items
Loading cancer entity…
Cancer Family
CI-CAN-00000185Explore in graph →
Clinical trials
3,258 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT02485015 | The Study of Apatinib Plus CIK as the Third Line Therapy for Patients With Advanced Gastric Cancer | active not recruiting | Phase 2 | 80 | The First People's Hospital of ChangzhouOTHER | 0 | Feb 19, 2016 | clinicaltrials |
Data updated 22 days agoSource updated Feb 19, 2016source: clinicaltrials